Understanding the pathologic basis of cognitive impairment in whole populations is a prerequisite to mitigating the increasing public health burden of dementia.
1 Many strands of investigation presuppose that Alzheimer, vascular, and Lewy body pathologic features are the predominant causes of dementia. This paradigm has directed the search for biomarkers, treatments, and potential prevention strategies. However, evidence indicates that these classic pathologic processes do not fully account for the clinical syndrome,
2 especially in unselected populations of the oldest-old.
3,4 For example, older people may have a large burden of the pathologic processes of classic dementia but no associated clinical dementia and vice versa.